Insights · Start here
What is agentic AI for pharma communications?
What makes an AI tool "agentic" rather than a writing assistant?
A writing assistant answers the request in front of it. You ask for a press release, it writes one, and it works from whatever is in the current conversation.
An agent holds a goal across steps. It can ask what it needs to know, decide which piece of work comes next, use tools (search, a document library, a calendar, a checking step), and keep track of what has already been decided. In communications that means it can move from "what is the situation?" to "what should we say, to whom, in what order?" to the drafts themselves, without the team re-explaining the brief at every step.
That capability is exactly why the question of control matters more, not less. A tool that can act across steps can also carry a mistake across steps.
What does an agent actually do across a pharma communications workflow?
The work of a pharma or biotech communications team already runs as a chain, whether or not anyone draws it:
- Counsel. Read the situation, name the risk, recommend a route.
- Strategy. Agree the objective, the audiences and the boundaries.
- Messages. Set the key messages, each with its proof points and the things it must never say.
- Plan. Build the workback: who needs what, by when, in what order.
- Materials. Draft the release, the Q&A, the internal note, the social copy, the meeting kit.
- Review. Prepare the work for medical, legal and regulatory review and track the round.
An agent earns its place when it carries the connections between those steps: a draft knows which confirmed message it came from, and a message knows which strategy it serves. When the strategy changes, the work built on the old version is flagged as out of date instead of silently living on.
Where must a human stay in charge?
In pharma communications three lines are not negotiable, and a well-built agent enforces them in the software rather than in a policy document:
- Only a named person confirms. The agent can recommend a strategy or propose messages. It cannot confirm them. Confirmation is a recorded act by an identified human.
- Nothing machine-made is "approved." The highest state an AI draft should ever reach is ready for human review. Approval belongs to your medical, legal and regulatory reviewers.
- Claims stay inside the evidence. Each message carries its proof and its do-not-say lines. A draft that breaks them should be stopped before a reviewer ever sees it, not caught in round three.
If a vendor cannot show you where each of those lines is enforced, the agent is a faster way to produce work your reviewers will have to catch.
How is an agent different from a chatbot with your documents attached?
A general chatbot with your files can summarize them and draft from them. Four things separate an agent built for this work:
| Question | Chatbot with documents | Agent built for regulated communications |
|---|---|---|
| Does it remember what was decided? | Only what is in the current conversation | Keeps a record of confirmed decisions and who confirmed them |
| What happens when the strategy changes? | Nothing; old drafts look as current as new ones | Downstream work is marked stale, never silently rewritten |
| Does it know what each message may not say? | Only if you paste the rules every time | Boundaries travel with each message into every draft |
| Can it say no? | It will usually write what you ask | Refuses claims beyond the evidence and offers the strongest true version |
The last row matters most under pressure. A useful test is to ask the tool, firmly and more than once, to write a sentence your evidence does not support. Our own pressure test of exactly that is in The CEO says publish. What should your AI say?.
What should a communications leader ask before trusting an agent?
Five questions separate a demonstration from a system you can put in front of your reviewers:
- Who confirms? Show me the step where a named person confirms the strategy and the messages, and what the agent cannot do before that step.
- What happens when something upstream changes? If the strategy is re-confirmed, what happens to the messages and drafts built on the old one?
- How does it keep versions true? When it adapts one approved message for patients, physicians, investors or another language, how does it check that the new version says no more than the approved one?
- What does it refuse? Ask it for an unsupported claim, then escalate. Does it hold, and does it offer something usable instead?
- Where is the record? Can you show a reviewer, or an auditor, who decided what and when?
How does CommsRx approach it?
CommsRx is built around one agent, Ally, and one chain: counsel, confirmed strategy, messages, plan, materials, review readiness and a recorded external review. Ally gives counsel, builds the plan and drafts, and checks each message variant she derives against the approved messages it came from: a variant may say less than the approved message, never more. Only a named person confirms; her work stops at "ready for review"; and CommsRx publishes and sends nothing itself. The record is append-only, so the history of who decided what cannot be quietly edited.
She works from situation playbooks for the moments that define the job, among them a Phase 3 topline readout, an FDA decision date, a safety issue and a crisis, and she prepares work for the Review Room, where reviewers' comments are organized and answered.
Related questions
About this page
Drafted with AI assistance from CommsRx's own product records, then edited and checked by Abhi Basu, founder of CommsRx and Signal Fidelity Group. Last reviewed October 19, 2026. Corrections: help@signalfidelitygroup.com.